Sub-chronic phencyclidine administration increases brain-derived neurotrophic factor in the RAT hippocampus

Schizophrenia Research

Volumn 94, Issue 1-3, 2007, Pages 371-372

  Harte, Michael K ^a   Cahir, Marie ^a   Gartlon, Jane E ^b   Jones, Declan N C ^b   Reynolds, Gavin P ^a  

^a QUEEN'S UNIVERSITY BELFAST   (United Kingdom)

^b GLAXOSMITHKLINE   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

BRAIN DERIVED NEUROTROPHIC FACTOR; PHENCYCLIDINE;

ENZYME LINKED IMMUNOSORBENT ASSAY; FRONTAL CORTEX; HIPPOCAMPUS; LETTER; NERVE DEGENERATION; NERVOUS SYSTEM DEVELOPMENT; NONHUMAN; PRIORITY JOURNAL; PSYCHOSIS; STATISTICAL SIGNIFICANCE;

ANIMALS; BRAIN-DERIVED NEUROTROPHIC FACTOR; DRUG ADMINISTRATION SCHEDULE; ENZYME INHIBITORS; HIPPOCAMPUS; PHENCYCLIDINE; RATS;

EID: 34447130838     PISSN: 09209964     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.schres.2007.04.032     Document Type: Letter

References (9)

1. Abdul-Monim Z., Neill J.C., and Reynolds G.P. Sub-chronic psychotomimetic phencyclidine induces deficits in reversal learning and alterations in parvalbumin-immunoreactive expression in the rat. J. Psychopharmacol. 21 (2007) 198-205
2. Ballarin M., Ernfors P., Lindefors N., and Persson H. Hippocampal damage and kainic acid injection induce a rapid increase in mRNA for BDNF and NGF in the rat brain. Exp. Neurol. 114 (1991) 35-43
3. Durany N., and Thome J. Neurotrophic factors and the pathophysiology of schizophrenic psychoses. Eur. Psychiatr. 19 (2004) 326-337
4. Goodman L.J., Valverde J., Lim F., Geschwind M.D., Federoff H.J., Geller A.I., and Hefti F. Regulated release and polarized localization of brain-derived neurotrophic factor in hippocampal neurons. Mol. Cell. Neurosci. 7 (1996) 222-238
5. Javitt D.C., and Zukin S.R. Recent advances in the phencyclidine model of schizophrenia. Am. J. Psychiatry 148 (1991) 1301-1308
6. Liu S., Wang J., Zhu D., Fu Y., Lukowiak K., and Lu Y.M. Generation of functional inhibitory neurons in the adult rat hippocampus. J. Neurosci. 23 (2003) 732-736
7. Olney J.W., and Farber N.B. Glutamate receptor dysfunction and schizophrenia. Arch. Gen. Psychiatry 52 (1995) 998-1007
8. Takahashi M., Shirakawa O., Toyooka K., Kitamura N., Hashimoto T., Maeda K., Koizumi S., Wakabayashi K., Takahashi H., Someya T., and Nawa H. Abnormal expression of brain-derived neurotrophic factor and its receptor in the corticolimbic system of schizophrenic patients. Mol. Psychiatry 5 (2000) 293-300
9. Zhang Z.J., and Reynolds G.P. A selective decrease in the relative density of parvalbumin-immunoreactive neurons in the hippocampus in schizophrenia. Schizophr. Res. 55 (2002) 1-10